ANDA 63187, held by Pliva. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 63187 (Doxycycline Hyclate), held by Pliva, was first approved by FDA on Jun 30, 1992, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 30, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxycycline HyclateEQ 100MG BASE · capsule, coated pellets;oral | Doxycycline Hyclate | Discontinued |
| Mar 31, 2025 | Supplement 6Labeling · Standard review | Approved | None posted |
| Mar 27, 2025 | Supplement 2Labeling · Standard review | Approved | None posted |
| Mar 27, 2025 | Supplement 3Labeling · Standard review | Approved | None posted |
| Mar 27, 2025 | Supplement 4Labeling · Standard review | Approved | None posted |
| Mar 27, 2025 | Supplement 5Labeling · Standard review | Approved | None posted |
| May 11, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Jun 30, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters